Funding for large Alzheimer's trial testing vitamin B3
The National Programme for Clinical Treatment Research in the Specialist Health Services (KLINBEFORSK) recently awarded NOK 25 million to a double-blinded trial investigating novel Alzheimer's disease therapy, involving patients with early Alzheimer's dementia from across Norway. This is a study in the Neuro-SysMed dementia node, with Kristoffer Haugarvoll as principal investigator.